INTERNATIONAL FLAVORS & FRAGRANCES (IFF)
Sector: Materials
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Materials
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for IFF
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| IFF | Chief Executive Officer; Director; Chair | 67 | ["Current or Prior CEO","Consumer Products","Mergers & Acquisitions / Integrations","Sustainability / Environmental","Finance / Accounting","ERM / Risk Management","International / Emerging Markets","Other Public Board Experience","CEO of Hevolution Foundation","Executive Chair of Life Biosciences","Former CEO of Life Biosciences (2019-2024)","Former Vice Chairman and Chief Scientific Officer of Global Research and Development at PepsiCo","Former President of Takeda Global Research & Development Center","Former faculty member at Mayo Clinic and Mayo Medical School","Director of the Diabetes, Endocrine and Nutritional Trials Unit","Leader of programs in diabetes, endocrinology, metabolism and nutrition at Hennepin County Medical Center","Director of Reckitt Benckiser (2018-2025)","Director of CorMedix Inc. (2017-2020)","Medical degree from University of Liverpool","Fellow of the Royal College of Physicians, London","Fellow of the American College of Endocrinology","Elected Fellow in the Department of Pharmacology at University of Oxford","Holds two Honorary PhDs in Humanities and International Law"] | ["Innovation","Human Capital & Compensation"] | 2026 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| CRMD | Director | 61 | [] | [] | 2019 |
| PEP | Vice Chairman, EVP and Chief Scientific Officer; Vice Chairman, EVP and CSO, Global Research & Development | ["Leadership in innovation efforts", "Extended innovation advantage", "Development of sustainability agenda"] | [] | 2017 |
Biography sourced from the proxy statement filing.
Dr. Khan is the CEO of Hevolution Foundation, a first-of-its-kind global non-profit organization with a mission to extend healthy lifespan for people everywhere. He was the Executive Chair of Life Biosciences after serving as the CEO from 2019 until 2024. Prior to this role, Dr. Khan served as PepsiCo s Vice Chairman and Chief Scientific Officer of Global Research and Development. Prior to joining PepsiCo, he was President of Takeda Global Research & Development Center, overseeing Takeda Pharmaceuticals Company s worldwide R&D efforts. Dr. Khan was also a faculty member at the Mayo Clinic and Mayo Medical School, serving as Director of the Diabetes, Endocrine and Nutritional Trials Unit in the endocrinology division. He also spent nine years leading programs in diabetes, endocrinology, metabolism and nutrition for the Hennepin County Medical Center. Dr. Khan was a director of Reckitt Benckiser, a multinational company that manufactures and markets products for the home, health and personal care, from 2018 to 2025, and CorMedix Inc., a biopharmaceutical company developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases, from 2017 to 2020. Dr. Khan has a medical degree from the University of Liverpool, is a Fellow of the Royal College of Physicians, London and of the American College of Endocrinology, an Elected Fellow in the Department of Pharmacology at University of Oxford and holds two Honorary PhDs in Humanities and International Law. Dr. Khan is a highly skilled medical practitioner and researcher with extensive experience in both developing and developed markets. He has a deep knowledge of creating sustainable initiatives and a track record of leading research and development efforts to create breakthrough innovations.